
Bristol-Myers (BMY) Earnings Dates & Reports
Bristol-Myers (BMY) Most Recent Earnings
Report Date
Period EndingQ2 2026
Est. EPS$1.61
Actual EPS$2.04
EarningsBeat
Bristol-Myers (BMY) Earnings
View the latest Bristol-Myers (BMY) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Bristol-Myers (BMY)
Order type
Buy in
Order amount
Est. shares
0 shares
Bristol-Myers (BMY) Earnings per Share (EPS) History
Signup for full accessBrowse free
Bristol-Myers (BMY) Latest Earnings
The value each BMY share was expected to gain vs. the value each share gained.
Bristol-Myers (BMY) reported its most recent earnings on for Q2 2026, posting earnings per share (EPS) of $2.04. This exceeded analysts' expectations of $1.61 by 26.71%, marking a Beat.
For comparison, Bristol-Myers reported EPS of $1.46 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $1.72.
Bristol-Myers (BMY) Earnings History
Bristol-Myers (BMY) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Bristol-Myers’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Bristol-Myers (BMY) Earnings FAQs
Bristol-Myers (BMY) last reported earnings on Jul 30, 2026 for Q2 2026, posting an EPS of $2.04, which Beat the estimate of $1.61 by 26.71%.
For Q2 2026, Bristol-Myers (BMY) reported an EPS of $2.04, exceeding analysts' estimate of $1.61 by 26.71%.
For Q2 2026, Bristol-Myers (BMY) Beat expectations with an actual EPS of $2.04 vs. an estimated EPS of $1.61.
Following the last earnings report on Jul 30, 2026, Bristol-Myers (BMY)'s stock price moved — from — to —.
The next Bristol-Myers (BMY) earnings call is scheduled for Oct. 29, 2026, where executives will discuss financial results and outlook.